GE HealthCare Technologies Inc. $GEHC Shares Purchased by Choreo LLC

Choreo LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 30,659 shares of the company’s stock after buying an additional 658 shares during the period. Choreo LLC’s holdings in GE HealthCare Technologies were worth $2,271,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of GEHC. Glenview Trust co increased its position in shares of GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after acquiring an additional 139 shares during the last quarter. Silver Oak Securities Incorporated increased its holdings in GE HealthCare Technologies by 4.6% in the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares during the last quarter. Chicago Capital LLC raised its position in GE HealthCare Technologies by 2.2% in the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after purchasing an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH raised its position in GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after purchasing an additional 143 shares during the period. Finally, Golden State Wealth Management LLC lifted its stake in GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after purchasing an additional 148 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $80.63 on Friday. The business has a 50-day simple moving average of $74.98 and a 200-day simple moving average of $74.12. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a market cap of $36.73 billion, a PE ratio of 16.66, a P/E/G ratio of 3.37 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter last year, the company earned $1.14 earnings per share. The firm’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, November 17th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Stifel Nicolaus set a $90.00 price target on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Barclays assumed coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $86.45.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.